Northern Trust’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.67M | Sell |
267,718
-17,896
| -6% | -$245K | ﹤0.01% | 2645 |
|
|
2025
Q1 | $3.16M | Sell |
285,614
-24,460
| -8% | -$271K | ﹤0.01% | 2670 |
|
|
2024
Q4 | $3.3M | Buy |
310,074
+23,345
| +8% | +$249K | ﹤0.01% | 2757 |
|
|
2024
Q3 | $3.64M | Buy |
286,729
+69,367
| +32% | +$881K | ﹤0.01% | 2661 |
|
|
2024
Q2 | $3.65M | Sell |
217,362
-15,138
| -7% | -$254K | ﹤0.01% | 2569 |
|
|
2024
Q1 | $3.49M | Sell |
232,500
-2,736
| -1% | -$41K | ﹤0.01% | 2691 |
|
|
2023
Q4 | $3.53M | Buy |
235,236
+57,845
| +33% | +$868K | ﹤0.01% | 2694 |
|
|
2023
Q3 | $2.49M | Sell |
177,391
-1,792
| -1% | -$25.1K | ﹤0.01% | 2817 |
|
|
2023
Q2 | $1.85M | Buy |
179,183
+157,725
| +735% | +$1.63M | ﹤0.01% | 3051 |
|
|
2023
Q1 | $198K | Sell |
21,458
-363
| -2% | -$3.35K | ﹤0.01% | 3862 |
|
|
2022
Q4 | $194K | Sell |
21,821
-177
| -0.8% | -$1.57K | ﹤0.01% | 3886 |
|
|
2022
Q3 | $183K | Buy |
21,998
+1,008
| +5% | +$8.39K | ﹤0.01% | 3911 |
|
|
2022
Q2 | $172K | Sell |
20,990
-139,890
| -87% | -$1.15M | ﹤0.01% | 3984 |
|
|
2022
Q1 | $1.4M | Sell |
160,880
-8,421
| -5% | -$73.3K | ﹤0.01% | 3267 |
|
|
2021
Q4 | $1.61M | Buy |
169,301
+1,277
| +0.8% | +$12.2K | ﹤0.01% | 3329 |
|
|
2021
Q3 | $2.83M | Sell |
168,024
-29,530
| -15% | -$497K | ﹤0.01% | 3094 |
|
|
2021
Q2 | $3.02M | Sell |
197,554
-9,742
| -5% | -$149K | ﹤0.01% | 3155 |
|
|
2021
Q1 | $4.04M | Sell |
207,296
-32,084
| -13% | -$625K | ﹤0.01% | 2876 |
|
|
2020
Q4 | $4.31M | Sell |
239,380
-6,583
| -3% | -$119K | ﹤0.01% | 2767 |
|
|
2020
Q3 | $4.75M | Buy |
245,963
+48,244
| +24% | +$931K | ﹤0.01% | 2565 |
|
|
2020
Q2 | $5.17M | Sell |
197,719
-32,308
| -14% | -$844K | ﹤0.01% | 2500 |
|
|
2020
Q1 | $4.1M | Buy |
230,027
+2,264
| +1% | +$40.4K | ﹤0.01% | 2420 |
|
|
2019
Q4 | $7.6M | Buy |
227,763
+4,056
| +2% | +$135K | ﹤0.01% | 2352 |
|
|
2019
Q3 | $5.33M | Buy |
223,707
+168,371
| +304% | +$4.01M | ﹤0.01% | 2513 |
|
|
2019
Q2 | $1.99M | Buy |
55,336
+29,142
| +111% | +$1.05M | ﹤0.01% | 3078 |
|
|
2019
Q1 | $968K | Buy |
26,194
+8,596
| +49% | +$318K | ﹤0.01% | 3371 |
|
|
2018
Q4 | $758K | Buy |
17,598
+1,600
| +10% | +$68.9K | ﹤0.01% | 3452 |
|
|
2018
Q3 | $756K | Buy |
15,998
+2,400
| +18% | +$113K | ﹤0.01% | 3542 |
|
|
2018
Q2 | $677K | Buy |
+13,598
| New | +$677K | ﹤0.01% | 3532 |
|